Pfizer's attractive dividend yield and low P/E ratio make it appealing. Learn why PFE stock's valuation risks may be higher ...

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

If you're looking for reasonably priced stocks to pick up right now, you shouldn't overlook Pfizer (NYSE: PFE). The ...

The most recent trading session ended with Pfizer (PFE) standing at $25.60, reflecting a -0.43% shift from the previouse trading day's closing. This change was narrower than the S&P 500's daily loss ...

Pfizer is ranked third among the best pharma stocks to buy according to hedge funds. The company boasts a strong oncology ...

Vepdegestrant did not improve progression-free survival broadly but saw improvements in one specific patient cohort. Arvinas’ ...

In a filing disclosed on March 06th, the Senator disclosed that they had sold between $1,001 and $15,000 in Pfizer stock on February 13th. Pfizer (NYSE:PFE – Get Free Report) last released its ...

The stock supports a dividend yield of 6.5%, as of March 6. Overall, PFE ranks 3rd on our list of best cheap dividend stocks to buy right now. While we acknowledge the potential for PFE as an ...

We recently published a list of 13 Best Cheap Dividend Stocks To Buy Right Now. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best cheap dividend ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Just because the stock market, or one of its widely followed indexes, corrects lower, it doesn't mean people suddenly stop getting sick or requiring medical care. Pfizer's novel-drug portfolio ...